Fig. 3: Analyses of treatment-free survival grouped by combined DNA ploidy and PTEN status. | British Journal of Cancer

Fig. 3: Analyses of treatment-free survival grouped by combined DNA ploidy and PTEN status.

From: DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance

Fig. 3

 a, c, e Time-invariant analyses. b, d, f Time-dependent analyses. a, b All patients. c, d Low-risk patients. e, f Intermediate-risk patients. CI confidence interval, DPP-normal DNA ploidy and PTEN “normal”, DPP-aberrant DNA ploidy and/or PTEN “aberrant”, HR hazard ratio.

Back to article page